A more accurate biomarker – osteopontin-c – has been identified by researchers  at University of Cincinnati that will predict if breast cancers will develop into an advanced form.
Currently, biomarkers used are elevated levels of three standard molecules known to make tumors grow in the breast: estrogen receptor (ER), progesterone receptor (PR) and HER — are used as “biomarkers” for diagnosis and individually detect only a fraction of breast cancers.
According to Georg Weber, MD, PhD, lead investigator of the new study and associate professor of pharmacy at the University of Cincinnati:
“The problem with these biomarkers is that many of them are …read more